Press Releases

BOSTON--(BUSINESS WIRE)-- Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that management will present at Credit Suisse’s 27th Annual Healthcare Conference in Scottsdale, AZ on Tuesday, November 13, 2018 at 10:00 a.m., ET. An audio webcast of the presentation will be available live. You can access the webcast at:

HOUSTON--(BUSINESS WIRE)-- SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc using Human Dermal Fibroblasts (HDFs), today announced the issuance of new patents in Hong Kong and Europe. The company’s industry leading intellectual property in spine treatments now includes 35 U.S. and foreign patents issued with 41 patents pending, which provide a commanding

JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Healogics®, the nation’s leading provider of advanced chronic wound care services, today unveiled t

WALTHAM, Mass.--(BUSINESS WIRE)-- Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today that management will present at two investor conferences in November as follows: Conference:  

BOSTON--(BUSINESS WIRE)-- Verastem, Inc. (Nasdaq: VSTM) (Verastem Oncology or the Company), focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today reported financial results for the third quarter ended September 30, 2018 and provided an overview of certain corporate developments. “During the third quarter, we achieved a remarkab

MOORESTOWN, N.J.--(BUSINESS WIRE)-- Destination Maternity Corporation (NASDAQ:DEST) (the “Company”), the world’s largest designer and retailer of maternity apparel, today announced in recognition of Veterans Day the launch of a military discount program that offers an ongoing 10% discount in-store for all veterans, active service members and their spouses. “Destination Materni

PHOENIX--(BUSINESS WIRE)-- Carvana Co. (NYSE: CVNA), a leading e-commerce platform for buying used cars, today announced financial results for the quarter ended September 30, 2018. Carvana’s complete third quarter 2018 financial results and management commentary can be found by accessing the Company’s shareholder letter on the

TORONTO--(BUSINESS WIRE)-- Superior Plus Corp.: November 2018 Cash Dividend - $0.06 per share Superior Plus Corp. (“Superior”) (TSX: SPB) today announced its cash dividend for the month of November 2018 of $0.06 per share payable on December 14, 2018. The record date is November 30, 2018 and the ex-dividend date will be November 29, 2018. Superior&r

LOS ANGELES--(BUSINESS WIRE)-- Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of the Company at 9:10 a.m. MST (8:10 a.m. PST, 11:10 a.m. EST) on Wednesday, November 14, at the Credit Suisse 27th Annual Healthcare Conference. The conference will be held at

DEARBORN, Mich.--(BUSINESS WIRE)-- On Wednesday, Nov. 14, Joe Hinrichs, Ford Motor Company’s executive vice president and president, global operations will present at Barclays Global Automotive Conference in New York. Hinrichs will provide an update on the company’s previously announced fitness initiatives, as well as progress the company is making to redesign its global operations by foc

BOCA RATON, Fla.--(BUSINESS WIRE)-- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, today announced its clinical and corporate update for the quarter ended September 30, 2018. “We are extremely pleased with the momentum of the IMVEXXY launch, including our progress with negotiating commercial payer coverage,” said Robert G. Finizio, Chief Executive Off

SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to transform the treatment of glaucoma, today announced financial results for the third quarter ended September 30, 2018. Key highlights include:

BRISBANE, Australia & CULVER CITY, Calif.--(BUSINESS WIRE)-- NantHealth (NASDAQ: NH), a leader in breakthrough cancer research and data solutions that improve patient care and

BRISBANE, Australia & CULVER CITY, Calif.--(BUSINESS WIRE)-- NantHealth (NASDAQ: NH), a leader in breakthrough cancer research and solutions to improve patient care and lower healthcare costs, today announced a collaboration with B. Braun Australia, GE Healthcare and iProcedures to demonstrate the exchange of data between devices and patient electronic medical records (EMRs). The demonstration is

CRANBURY, N.J.--(BUSINESS WIRE)-- Targeted Therapies in Oncology, an oncology publication that provides oncology professionals with cutting-edge research, data, and treatment strategies surrounding molecular and immune system targets, has appointed Robert L. Ferris, M.D., Ph.D., as its co-physician editor-in-chief. “We look forward to having Dr. Ferris joining the Targeted Ther